株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

先進的創傷ケア市場予測 (2017〜2027年):アクティブ創傷ケアドレッシング (抗菌剤、フォーム、ハイドロコロイド、フィルム、アルギン酸塩、ハイドロゲル、その他) 、創傷ケア装置 (NPWT、超音波、その他) 、創傷ケア生物製剤

Advanced Wound Care Market Forecast 2017-2027: Revenue Prospects for Active Wound Care Dressings (Antimicrobial, Foam, Hydrocolloid, Film, Alginate, Hydrogel, Other), Wound Care Devices (NPWT, Ultrasound, Other), Wound Care Biologics, and Geography

発行 Visiongain Ltd 商品コード 226944
出版日 ページ情報 英文 234 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1GBP=155.63円で換算しております。

ご注意:
Single UserとDepartmentalライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。制限内容は、上記ライセンスの[?]アイコンをクリックしてご確認ください。

Back to Top
先進的創傷ケア市場予測 (2017〜2027年):アクティブ創傷ケアドレッシング (抗菌剤、フォーム、ハイドロコロイド、フィルム、アルギン酸塩、ハイドロゲル、その他) 、創傷ケア装置 (NPWT、超音波、その他) 、創傷ケア生物製剤 Advanced Wound Care Market Forecast 2017-2027: Revenue Prospects for Active Wound Care Dressings (Antimicrobial, Foam, Hydrocolloid, Film, Alginate, Hydrogel, Other), Wound Care Devices (NPWT, Ultrasound, Other), Wound Care Biologics, and Geography
出版日: 2017年09月19日 ページ情報: 英文 234 Pages
概要

世界の先進的創傷ケア市場は2017年に149億米ドルを超えるとみられています。同市場は2027年にかけ収益が安定して成長すると予測されています。

当レポートでは、世界の先進的創傷ケア市場について調査し、今後の収益予測、地域別動向、および市場に参入する主要企業のプロファイルなどをまとめています。

第1章 当レポートの概要

第2章 イントロダクション

  • 皮膚、創傷、創傷治癒のイントロダクション
  • 創傷ケアのイントロダクション
  • 創傷ケア治療の分類
  • 医療機器の法規制

第3章 世界市場

  • 創傷ケア:世界市場ギア用
  • 世界の先進的創傷ケア市場
  • 売上予測
  • セグメント別市場シェア
  • 市場促進因子と阻害因子

第4章 アクティブ創傷ケア市場

  • 市場概要
  • 市場予測
  • タイプ別製品
  • 抗菌ドレッシング
  • フォームドレッシング
  • ハイドロコロイドドレッシング
  • フィルムドレッシング
  • アルギン酸塩ドレッシング
  • ハイドロゲルドレッシング
  • その他
  • SWOT分析

第5章 創傷ケア装置市場

  • 市場概要
  • 市場予測
  • タイプ別市場
  • 陰圧創傷治療 (NPWT)
  • 超音波
  • 創傷ケア装置パイプライン分析
  • SWOT分析

第6章 創傷ケア生物製剤市場

  • 市場概要
  • 市場予測
  • タイプ別市場シェア
  • 皮膚置換療法
  • コラーゲン治療
  • 細胞ベース治療
  • その他
  • パイプライン分析
  • SWOT分析

第7章 主要国市場

  • 地域別分類
  • 地域別予測
  • 米国
  • EU5か国
  • 日本
  • 中国
  • インド
  • ロシア
  • ブラジル
  • 韓国

第8章 定性分析

  • ポーターズファイブフォース
  • PESTLE

第9章 主要企業

  • Smith & Nephew
  • Acelity (KCI, Systagenix and LifeCell)
  • Molnlycke
  • ConvaTec
  • Coloplast
  • Organogenesis

第10章 結論

第11章 用語

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: PHA0239

Advanced Wound Care - our new study reveals trends, R&D progress, and predicted revenues

Where is the Advanced Wound Care market heading? If you are involved in this sector you must read this newly updated report. Visiongain's report shows you the potential revenues streams to 2027, assessing data, trends, opportunities and business prospects there.

Discover how to stay ahead

Our 234-page report provides 116 tables, charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Advanced Wound Care market. See how to exploit the opportunities.

Forecasts to 2027 and other analyses reveal the commercial prospects

  • In addition to revenue forecasting to 2027, our new study provides you with recent results, growth rates, and market shares.
  • You find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.

Discover sales predictions for the world market and submarkets

Along with revenue prediction for the overall world market, there are forecasts for 3 Classes of Advanced Wound Care Products, with additional forecasts for 10 types of Advanced Wound Care products.

Active Wound Care Dressings, by Indication

  • Antimicrobial
  • Foam
  • Hydrocolloid
  • Film
  • Alginate
  • Hydrogel
  • Other

image1

Advanced Wound Care Devices

  • Negative Pressure Wound Therapy (NWPT)
  • Ultrasound Wound Therapy
  • Other

Advanced Wound Care Biologics

  • Skin Replacement Therapy
  • Collagen-Based Therapy
  • Cell-Based Therapy
  • Other

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 19 leading national markets:

  • The U.S.
  • Germany
  • France
  • The UK
  • Italy
  • Spain
  • Japan
  • China
  • India
  • Russia
  • Brazil
  • South Korea

The report also includes profiles and for some of the leading companies in the Advanced Wound Care market, with a focus on this segment of these companies' operations.

There will be growth in both established and in developing countries. Our analyses show that the both developed and developing markets, China, India and South Korea in particular, will continue to achieve high revenue growth to 2027.

Leading companies and the potential for market growth

Overall world revenue for Advanced Wound Care will surpass $14.9bn in 2017, our work calculates. We predict strong revenue growth through to 2027.

Our work identifies which organisations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Advanced Wound Care Market report helps you

In summary, our 234-page report provides you with the following knowledge:

  • Revenue forecasts to 2027 for the Advanced Wound Care market with forecasts for 3 Types of Advanced Wound Care and 10 Types of Wound Care Product - discover the industry's prospects, finding the most lucrative places for investments and revenues
  • Revenue forecasts to 2027 for 12 key national markets - See forecasts for the Advanced Wound Care market in the US, Brazil, Germany, France, the UK, Italy, Spain, Japan, China, India, South Korea and Russia.
  • Discussion of what stimulates and restrains companies and the market
  • Prospects for established firms and those seeking to enter the market - including company profiles for 6 of the major companies involved in the Advanced Wound Care market

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else

With our newly updated report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions.

Visiongain's study is for everybody needing commercial analyses for the Advanced Wound Care market and leading companies. You will find data, trends and predictions.

Table of Contents

1. Report Overview

  • 1.1 Global Advanced Wound Care Market Overview
  • 1.2 Global Advanced Wound Care Market Segmentation
  • 1.3 Overview of Findings
  • 1.4 Structure of the Report
  • 1.5 Why You Should Read This Report
  • 1.6 How This Report Delivers
  • 1.7 Key Questions Answered by This Analytical Report
  • 1.8 Who is This Report For?
  • 1.9 Methodology
  • 1.10 Frequently Asked Questions (FAQ)
  • 1.11 Associated Visiongain Reports
  • 1.12 About Visiongain

2. Introduction to Wounds and Wound Care

  • 2.1 An Introduction to Skin, Wound and Wound Healing
    • 2.1.1 Acute Wounds
    • 2.1.2 Chronic Wounds
    • 2.1.3 Burns
    • 2.1.4 The Phases of Wound Healing
      • 2.1.4.1 The Inflammatory Phase
      • 2.1.4.2 The Proliferation Phase
      • 2.1.4.3 The Fibroblastic Phase
      • 2.1.4.4 The Maturation Phase
  • 2.2 An Introduction to Wound Care
    • 2.2.1 The Role of Wound Dressing
    • 2.2.2 Wound Care: A Journey through History
  • 2.3 Classification of Wound Care Therapies
    • 2.3.1 Traditional Wound Care
      • 2.3.1.1 Composite Dressings
      • 2.3.1.2 Absorptive Dressings
      • 2.3.1.3 Gauze Dressings
      • 2.3.1.4 Contact Layers
      • 2.3.1.5 Compression Therapy
    • 2.3.2 Advanced Wound Care
      • 2.3.2.1 Active Wound Care Dressings
        • 2.3.2.1.1 Foam Dressings
        • 2.3.2.1.2 Hydrocolloid Dressings
        • 2.3.2.1.3 Alginate Dressings
        • 2.3.2.1.4 Hydrogel Dressings
      • 2.3.2.2 Wound Care Devices
        • 2.3.2.2.1 Negative Pressure Wound Therapy (NPWT)
        • 2.3.2.2.2 Ultrasound for Wound Therapy
      • 2.3.2.3 Wound Care Biologics
        • 2.3.2.3.1 Skin Replacement Therapies
        • 2.3.2.3.2 Collagen-Based Therapies
        • 2.3.2.3.3 Cell-Based Therapies
  • 2.4 Regulation of Medical Devices
    • 2.4.1 The US Approval and Regulation System
    • 2.4.2 The EU Approval and Regulation System
    • 2.4.2.1 Post-Marketing Surveillance in the EU
    • 2.4.3 Advanced Wound Care Market Drivers
      • 2.4.3.1 Increase in Aging Population:
      • 2.4.3.2 Lifestyle Factors
      • 2.4.3.3 Growing Incidence of Diabetes, Ulcers and Chronic Wounds
      • 2.4.3.4 Increasing Healthcare Expenditure, Increase in Surgeries
        • 2.4.3.4.1 North America
        • 2.4.3.4.2 Latin America
        • 2.4.3.4.3 Asia-Pacific
        • 2.4.3.4.4 Middle East and Africa
      • 2.4.3.5 Other Factors Driving the Growth of the Advanced Wound Care Market
        • 2.4.3.5.1 Technological Advancements and Government Initiatives
    • 2.4.4 Restraints
      • 2.4.4.1 High Cost Procedures
      • 2.4.4.2 Disparity in Reimbursements
    • 2.4.5 Market Opportunities
      • 2.4.5.1 Significant Growth Opportunities in Asia-Pacific and Developing Countries
      • 2.4.5.2 Healthy Growth in the Active Wound Care Market
    • 2.4.6 Market Challenges
      • 2.4.6.1 Reluctance to Accept New Technologies

3. Advanced Wound Care: World Market 2017-2027

  • 3.1 Wound Care: Global Market Overview, 2016
  • 3.2 The World Advanced Wound Care Market
  • 3.3 World Advanced Wound Care Market: Sales Forecast 2017-2027
  • 3.4 Changing Market Shares by Segment 2017-2027
  • 3.5 Advanced Wound Care Market: Drivers and Restraints 2017-2027

4. Active Wound Care Market 2017-2027

  • 4.1 Active Wound Care Market Overview
  • 4.2 Active Wound Care: Market Forecast 2017-2027
  • 4.3 Market Share of Active Wound Care Products by Type
  • 4.4 Antimicrobial Dressings, 2016-2027
  • 4.5 Leading Products in the Antimicrobial Dressings Market, 2016-2027
    • 4.5.1 Silver Dressings
      • 4.5.1.1 Allevyn Ag (Smith & Nephew)
      • 4.5.1.2 Acticoat (Smith & Nephew)
      • 4.5.1.3 Aquacel Ag Dressings (ConvaTec)
      • 4.5.1.4 Actisorb Silver 220 (Acelity)
    • 4.5.2 Iodine Dressings
      • 4.5.2.1 Inadine (Acelity)
      • 4.5.2.2 Idosorb and Idoflex (Smith & Nephew)
    • 4.5.3 Honey Dressings
      • 4.5.3.1 MediHoney (DermaSciences)
      • 4.5.3.2 Actilite (Advancis Medical)
  • 4.6 Foam Dressings: Market Forecast, 2016-2027
  • 4.7 Leading Products in the Foam Dressings Market
    • 4.7.1 Lyofoam (Mölnlycke)
    • 4.7.2 Allevyn (Smith & Nephew)
    • 4.7.3 Biatain (Coloplast)
  • 4.8 Hydrocolloid Dressings: Market Forecast, 2016-2027
  • 4.9 Leading Products in the Hydrocolloid Dressing Market
    • 4.9.1 DuoDerm (ConvaTec)
    • 4.9.2 Tegaderm Hydrocolloid (3M)
  • 4.10 Film Dressings: Market Forecast, 2016-2027
  • 4.11 Leading Products in the Film Dressings Market
    • 4.11.1 Mepitel Film (Mölnlycke)
    • 4.11.2 Mepore Film (Mölnlycke)
    • 4.11.3 OpSite Flexigrid (Smith-Nephew)
    • 4.11.4 Xtrata Perme Roll (NITTO DENKO CORPORATION)
  • 4.12 Alginate Dressings: Market Forecast, 2016-2027
  • 4.13 Leading Products in the Alginate Dressing Market
    • 4.13.1 Sorbsan (Aspen)
    • 4.13.2 Kaltostat (ConvaTec)
  • 4.14 Hydrogel Dressings: Market Forecast, 2016-2027
  • 4.15 Leading Products in the Hydrogel Dressing Market
    • 4.15.1 ActiFormCool (Activa Healthcare)
    • 4.15.2 Intrasite Conformable (Smith & Nephew)
  • 4.16 Other Active Wound Care Dressings
  • 4.17 Active Wound Care Pipeline Analysis 2017-2027
    • 4.17.1 ProNOx1 (EdixoMed)
  • 4.18 SWOT Analysis of the Active Wound Care Market, 2017-2027
    • 4.18.1 Strengths
      • 4.18.1.1 Greater Effectiveness Compared with Traditional Wound Care
      • 4.18.1.2 Large Range of Available Products
    • 4.18.2 Weaknesses
      • 4.18.2.1 A Diminishing R&D Pipeline
      • 4.18.2.2 Lower Effectiveness in Comparison to Some Devices and Biologics
    • 4.18.3 Opportunities
      • 4.18.3.1 More Affordable Compared to Other Devices and Biologics
      • 4.18.3.2 Increasing Prevalence of Chronic Wounds
    • 4.18.4 Threats
      • 4.18.4.1 The Threat of Emerging Technologies
      • 4.18.4.2 Decreasing R&D Funding Will Impact Innovation

5. Wound Care Devices Market 2017-2027

  • 5.1 Wound Care Devices Market Overview
  • 5.2 Wound Care Devices: Market Forecast 2016-2027
  • 5.3 Market Share of Leading Wound Care Devices by Type
  • 5.4 Negative Pressure Wound Therapy (NPWT): Market Forecast, 2016-2027
  • 5.5 Leading Products in the NPWT Market
    • 5.5.1 V.A.C. Therapy (KCI an Acelity Company)
    • 5.5.2 Renasys (Smith & Nephew)
    • 5.5.3 SNaP (Acelity)
    • 5.5.4 Other NPWT Devices
  • 5.6 Ultrasound Wound Therapy: Market Forecast, 2016-2027
  • 5.7 Leading Products in the Ultrasound Wound Therapy Market
    • 5.7.1 MIST Therapy (Alliqua BioMedical)
    • 5.7.2 Other Ultrasound Devices
  • 5.8 Other Wound Care Devices: Market Forecast, 2016-2027
  • 5.9 Leading Products in the Other Wound Care Device Market
    • 5.9.1 Micro-Z Mini DC Stimulator (Prizm Medical)
  • 5.10 Wound Care Devices Pipeline Analysis 2017-2027
    • 5.10.1 dermaPACE (Sanuwave Health)
    • 5.10.2 Red Light Wave Therapy (Lightwave Technologies)
  • 5.11 SWOT Analysis of the Wound Care Devices Market, 2017-2027
    • 5.11 1 Strengths
      • 5.11.1.1 Continuous Innovation and a Strong R&D Pipeline
      • 5.11.1.2 Higher Effectiveness Compared with Other Treatments
    • 5.11.2 Weaknesses
      • 5.11.2.1 The Dominance of Negative Pressure Wound Therapy
      • 5.11.2.2 An Oligopolistic Market
    • 5.11.3 Opportunities
      • 5.11.3.1 Decreasing Prices Will Drive Market Growth
      • 5.11.3.2 Increasing Prevalence of Chronic Wounds
    • 5.11.4 Threats
      • 5.11.4.1 Litigation: A Threat to Innovation

6. Wound Care Biologics Market 2017-2027

  • 6.1 Wound Care Biologics Market Overview
  • 6.2 Wound Care Biologics: Market Forecast 2017-2027
  • 6.3 Market Share of Leading Wound Care Biologics by Type
  • 6.4 Skin Replacement Therapy: Market Forecast, 2016-2027
  • 6.5 Leading Products in the Skin Replacement Therapy Market
    • 6.5.1 Apligraf (Organogenesis)
    • 6.5.2 Dermagraft (Organogenesis)
    • 6.5.3 EpiFix (MiMedX)
    • 6.5.4 Graftjacket (Acelity)
    • 6.5.5 Other Skin Replacement Therapies
  • 6.6 Collagen-Based Therapy: Market Forecast, 2016-2027
  • 6.7 Leading Products in the Collagen-Based Therapy Market
    • 6.7.1 BioStep (Smith & Nephew)
    • 6.7.2 SkinTemp (Human BioScience)
    • 6.7.3 Promogran (Acelity)
    • 6.7.4 Other Collagen-Based Therapies
  • 6.8 Cell-Based Therapy: Market Forecast, 2016-2027
  • 6.9 Leading Products in the Cell-Based Therapy Market
    • 6.9.1 Regranex (Smith & Nephew)
    • 6.9.2 Aurix System (Nuo Therapeutics)
    • 6.9.3 Other Cell-Based Therapies
  • 6.10 Other Biologics: Market Forecast, 2016-2027
  • 6.11 Leading Products in the Other Biologic Therapy Market
    • 6.11.1 Santyl (Smith & Nephew)
  • 6.12 Wound Care Biologics Pipeline Analysis 2017-2027
    • 6.12.1 CureXcell (Macrocure)
    • 6.12.2 Skin Cell Gun (Mc Gowan Institute for Regenerative Medicine: University of Pittsburgh)
    • 6.12.3 Mesenchymal Stem Cells (Nara University)
    • 6.12.4 Phytochemical Tissue Bonding (Harvard University Institute of Photomedicine)
    • 6.12.5 HP802-247 (Smith & Nephew)
    • 6.12.6 DermaFuse (Missouri S&T and Mo-Sci Corporation)
    • 6.12.7 e-Skin (UC Berkeley)
    • 6.12.8 Automated Artificial Skin Production (Fraunhofer Institute)
    • 6.12.9 Collagen-Based Wound Therapy (Cornell University)
    • 6.12.10 ReCell (Avita Medical)
    • 6.12.11 RIKEN Center for Developmental Biology
  • 6.13 SWOT Analysis of the Wound Care Biologics Market, 2017-2027
    • 6.13.1 Strengths
      • 6.13.1.1 Fresh Innovations Producing New Technologies
      • 6.13.1.2 Greater Effectiveness of Biologics
      • 6.13.1.3 Rich R&D Pipeline: A Driver for Market Growth
    • 6.13.2 Weaknesses
      • 6.13.2.1 Barriers to Entry: High
      • 6.13.2.2 The Dominance of Small Biotech Companies
      • 6.13.2.3 Price: A Potential Restraint to Reimbursement
    • 6.13.3 Opportunities
      • 6.13.3.1 The Prospect of Diagnostic Testing
      • 6.13.3.2 Rising Prevalence of Chronic Wounds
      • 6.13.3.3 Stem Cells for the Treatment of Multiple Indications
    • 6.13.4 Threats
      • 6.13.4.1 The Competition from Active Wound Care and Devices
      • 6.13.4.2 High Risk: A Strong Deterrent

7. Leading National Markets 2017-2027

  • 7.1 Geographical Breakdown of the World Advanced Wound Care Market
  • 7.2 World Advanced Wound Care Market: Regional Forecast 2017-2027
    • 7.2.1 How Will Regional Market Shares Change to 2027?
  • 7.3 The US Advanced Wound Care Market 2017-2027
    • 7.3.1 US Advanced Wound Care Market Forecast 2017-2027
    • 7.3.2 US Advanced Wound Care Market: Trends and Developments
      • 7.3.1.1 The ACA is Favourable to Pharmaceuticals:
      • 7.3.1.2 A Slow Repeal Could Remove or Alter Taxes and Fees Paid by Pharmaceuticals
      • 7.3.1.3 A Slow Repeal Could Remove or Alter Taxes and Fees Paid by Pharma Drug Price Controls and Importing Drugs from Other Countries
  • 7.4 The EU5 Advanced Wound Care Market 2017-2027
    • 7.4.1 Clinical Trials
    • 7.4.2 Regulation of Quality Assurance of Medicinal Products:
    • 7.4.3 Obtaining Marketing Authorization
    • 7.4.4 EU5 Advanced Wound Care Market Forecast 2017-2027
      • 7.4.4.1 German Advanced Wound Care Market Forecast 2017-2027
      • 7.4.1.2 French Advanced Wound Care Market Forecast 2017-2027
      • 7.4.1.3 UK Advanced Wound Care Market Forecast 2017-2027
      • 7.4.1.4 Spanish Advanced Wound Care Market Forecast 2017-2027
      • 7.4.1.5 Italian Advanced Wound Care Market Forecast 2017-2027
  • 7.5 The Japanese Advanced Wound Care Market 2017-2027
    • 7.5.1 Japanese Advanced Wound Care Market Forecast 2017-2027
    • 7.5.2 Japanese Advanced Wound Care Market: Trends and Developments
  • 7.6 The Chinese Advanced Wound Care Market 2017-2027
    • 7.6.1 Chinese Advanced Wound Care Market Forecast 2017-2027
    • 7.6.2 Chinese Advanced Wound Care Market: Trends and Developments
  • 7.7 The Indian Advanced Wound Care Market 2017-2027
    • 7.7.1 Indian Advanced Wound Care Market Forecast 2017-2027
    • 7.7.2 Indian Advanced Wound Care Market: Trends and Developments
  • 7.8 The Russian Advanced Wound Care Market 2017-2027
    • 7.8.1 Russian Advanced Wound Care Market Forecast 2016-2027
    • 7.8.2 Russian Advanced Wound Care Market: Trends and Developments
  • 7.9 The Brazilian Advanced Wound Care Market 2017-2027
    • 7.9.1 Brazilian Advanced Wound Care Market Forecast 2017-2027
    • 7.9.2 The Evolving Brazilian NPWT Market
    • 7.9.3 Multinationals to Expand in Brazil
  • 7.10 The South Korean Advanced Wound Care Market 2017-2027
    • 7.10.1 South Korean Advanced Wound Care Market Forecast 2017-2027
    • 7.10.2 South Korean Advanced Wound Care Market: Trends and Developments

8. Qualitative Analysis of the Advanced Wound Care Market

  • 8.1 Porter's Five Forces:
    • 8.1.1 Threat of Substitutes
    • 8.1.2 Bargaining power of buyers
    • 8.1.3 Bargaining power of suppliers
    • 8.1.4 Threat of new entries
  • 8.2 PESTLE
    • 8.2.1 Political
      • 8.2.1.1 Factors affecting wound care and management market
        • 8.2.1.1.1 Regulatory Bodies
        • 8.2.1.1.2 Insurance / Reimbursement
    • 8.2.2 Economical
    • 8.2.3 Social
    • 8.2.4 Technological
      • 8.2.4.1 Cost Implications
    • 8.2.5 Legal
      • 8.2.5.1 Process Documentation
      • 8.2.5.2 Patient's Consent
      • 8.2.5.3 Lawsuits and Litigations
    • 8.2.6 Environmental
      • 8.2.6.1 Effects of Regional Environment
      • 8.2.6.2 Marine life endangerment

9. Leading Companies in the Advanced Wound Care Market

  • 9.1 Smith & Nephew
    • 9.1.1 Smith & Nephew: Advanced Wound Care Product Portfolio
    • 9.1.2 Smith & Nephew: Financial Overview
    • 9.1.3 Smith & Nephew: Recent Development
  • 9.2 Acelity (KCI, Systagenix and LifeCell)
    • 9.2.1 Acelity: Advanced Wound Care Product Portfolio
    • 9.2.2 Acelity: Financial Overview
    • 9.2.3 Acelity: Recent Developments
      • 9.2.3.1 Acelity Acquires SNaP from Spiracur Inc
      • 9.2.3.2 Acelity Forms Partnership with B. Braun Medical
      • 9.2.3.3 Acquisition of Brazilian, Turkish and Indian Distributors KCI Forming
      • 9.2.3.4 Strengthening Distribution Ties in Europe
      • 9.2.3.5 Positive Clinical Evidence for V.A.C
      • 9.2.3.6 New Launches
  • 9.3 Mölnlycke
    • 9.3.1 Mölnlycke: Advanced Wound Care Product Portfolio
    • 9.3.2 Mölnlycke: Financial Overview
    • 9.3.3 Mölnlycke: Recent Developments
  • 9.4 ConvaTec
    • 9.4.1 ConvaTec: Advanced Wound Care Product Portfolio
    • 9.4.2 ConvaTec: Financial Overview
    • 9.4.3 ConvaTec: Recent Developments
      • 9.4.3.1 Cease of Manufacturing Operations
      • 9.4.3.2 New Launches
  • 9.5 Coloplast
    • 9.5.1 Coloplast: Advanced Wound Care Product Portfolio
    • 9.5.2 Coloplast: Financial Overview
  • 9.6 Organogenesis
    • 9.6.1 Organogenesis: Advanced Wound Care Product Portfolio
    • 9.6.2 Organogenesis: Financial Overview
    • 9.6.3 The End of Lawsuit between MiMedx
    • 9.6.4 Clinical Evidence Proves Aligraf and Dermagraft Superiority
    • 9.6.5 First Marketing Approval in A European Country

10. Conclusions

  • 10.1 The World Advanced Wound Care Market in 2015 and 2016
    • 10.1.1 Current Leading Advanced Wound Care Segments
    • 10.1.2 Leading Advanced Wound Care Companies
    • 10.1.3 Leading Regional Markets
  • 10.2 World Advanced Wound Care Market Forecast 2017-2027
  • 10.3 The Future of the Advanced Wound Care Market?

11. Glossary

  • Associated Visiongain Reports
  • Visiongain Report Sales Order Form
  • Appendix A
  • About Visiongain
  • Appendix B
  • Visiongain Report Evaluation Form

List of Figures

  • Figure 1.1 World Diabetes Prevalence by Country, 2014
  • Figure 1.2 Global Advanced Wound Care Market Segmentation Overview, 2017
  • Figure 2.1 Wound Healing Phases and Duration (Days)
  • Figure 2.2 Wound Healing Phases and Time Scales
  • Figure 2.3 Functions of Wound Dressings
  • Figure 3.1 Global Wound Care Market by Sector: Market Share (%), 2017
  • Figure 3.2 World Advanced Wound Care Market Forecast: Revenue ($bn) and AGR (%), 2016-2027
  • Figure 3.3 Advanced Wound Care Market by Segment: Market Shares (%),2017
  • Figure 3.4 Advanced Wound Care Market by Segment: Market Shares (%), 2022
  • Figure 3.5 Advanced Wound Care Market by Segment: Market Shares (%), 2027
  • Figure 3.6 Advanced Wound Care Market: Drivers and Restraints, 2017-2027
  • Figure 4.1 Active Wound Care Market Forecast: Revenue ($bn) and AGR (%), 2016-2027
  • Figure 4.2 Active Wound Care Market by Segment: Market Shares (%), 2017
  • Figure 4.3 Active Wound Care Market by Segment: Market Shares (%), 2021
  • Figure 4.4 Active Wound Care Market Share (%) by Segment: Market Shares (%), 2027
  • Figure 4.5 Antimicrobial Dressings Market Forecast: Revenue ($bn) and AGR (%), 2016-2027
  • Figure 4.6 Foam Dressings Market Forecast: Revenue ($bn) and AGR (%), 2016-2027
  • Figure 4.7 Hydrocolloid Dressings Market Forecast: Revenue ($bn) and AGR (%), 2016-2027
  • Figure 4.8 Film Dressings Market Forecast: Revenue ($bn) and AGR (%), 2016-2027
  • Figure 4.9 Alginate Dressings Market Forecast: Revenue ($bn) and AGR (%), 2016-2027
  • Figure 4.10 Hydrogel Dressings Market Forecast: Revenue ($bn) and AGR (%), 2016-2027
  • Figure 5.1 Wound Care Device Market Forecast: Revenue ($bn) and AGR (%), 2016-2027
  • Figure 5.2 Wound Care Device Market by Device Type: Market Shares (%), 2016
  • Figure 5.3 Wound Care Device Market by Device Type: Market Shares (%), 2022
  • Figure 5.4 Wound Care Device Market by Device Type: Market Shares (%), 2027
  • Figure 5.5 NPWT Market Forecast: Revenue ($bn) and AGR (%),2016-2027
  • Figure 5.6 Ultrasound Wound Therapy Market Forecast: Revenue ($bn) and AGR (%), 2016-2027
  • Figure 5.7 Other Wound Care Device Market Forecast: Revenue ($bn) and AGR (%), 2016-2027
  • Figure 6.1 Wound Care Biologics Market Forecast: Revenue ($bn) and AGR (%), 2016-2027
  • Figure 6.2 Wound Care Biologics Market by Type: Market Shares (%), 2016
  • Figure 6.3 Wound Care Biologics Market by Type: Market Shares (%), 2022
  • Figure 6.4 Wound Care Biologics Market by Type: Market Shares (%), 2026
  • Figure 6.5 Skin Replacement Therapy Market Forecast: Revenue ($bn) and AGR (%), 2016-2027
  • Figure 6.6 Collagen-Based Therapy Market Forecast: Revenue ($bn) and AGR (%), 2016-2027
  • Figure 6.7 Cell-Based Therapy Market Forecast: Revenue ($bn) and AGR (%), 2015-2026
  • Figure 6.8 Other Biologics Market Forecast: Revenue ($bn) and AGR (%), 2015-2026
  • Figure 7.1 World Advanced Wound Care Market by Region: Revenues ($bn), 2016
  • Figure 7.2 World Advanced Wound Care Market by Region: Revenues ($bn), 2027
  • Figure 7.3 World Advanced Wound Care Market by Region: Revenues ($bn), 2016-2027
  • Figure 7.4 World Advanced Wound Care Market by Region: Market Shares (%), 2016
  • Figure 7.5 World Advanced Wound Care Market by Region: Market Shares (%), 2021
  • Figure 7.6 World Advanced Wound Care Market by Region: Market Shares (%), 2027
  • Figure 7.7 US Advanced Wound Care Market Forecast: Revenues ($bn) and AGR (%), 2016-2027
  • Figure 7.8 EU5 Advanced Wound Care Market Forecast: Revenues ($bn) and AGR (%), 2015-2026
  • Figure 7.9 EU5 Advanced Wound Care Market: Market Shares (%) by National Market, 2016
  • Figure 7.10 EU5 Advanced Wound Care Market: Market Shares (%) by National Market, 2022
  • Figure 7.11 EU5 Advanced Wound Care Market: Market Shares (%) by National Market, 2027
  • Figure 7.12 German Advanced Wound Care Market Forecast: Revenues ($bn) and AGR (%), 2016-2027
  • Figure 7.13 French Advanced Wound Care Market Forecast: Revenues ($bn) and AGR (%), 2016-2027
  • Figure 7.14 UK Advanced Wound Care Market Forecast: Revenues ($bn) and AGR (%), 2016-2027
  • Figure 7.15 Spanish Advanced Wound Care Market Forecast: Revenues ($bn) and AGR (%), 2016-2027
  • Figure 7.16 Italian Advanced Wound Care Market Forecast: Revenues ($bn) and AGR (%), 2016-2207
  • Figure 7.17 Japanese Advanced Wound Care Market Forecast: Revenues ($bn) and AGR (%), 2016-2027
  • Figure 7.18 Chinese Advanced Wound Care Market Forecast: Revenues ($bn) and AGR (%), 2016-2027
  • Figure 7.19 Indian Advanced Wound Care Market Forecast: Revenues ($bn) and AGR (%), 2016-2027
  • Figure 7.20 Russian Advanced Wound Care Market Forecast: Revenues ($bn) and AGR (%), 2016-2027
  • Figure 7.21 Brazilian Advanced Wound Care Market Forecast: Revenues ($bn) and AGR (%), 2016-2027
  • Figure 7.22 South Korean Advanced Wound Care Market Forecast: Revenues ($bn) and AGR (%), 2015-2026
  • Figure 9.1 Smith & Nephew: Advanced Wound Care Revenue ($bn) and AGR (%), 2016-2027
  • Figure 9.2 Acelity: Advanced Wound Care Revenue ($bn) and AGR (%), 2015-2026
  • Figure 9.3 ConvaTec: Advanced Wound Care Historical Sales ($bn), AGR (%), CAGR (%), 2015-2026
  • Figure 9.4 Coloplast: Advanced Wound Care Revenue ($bn) and AGR (%), 2016-2027

List of Tables

  • Table 1.1 Advanced Wound Care Market Forecast Segmented by National Market: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027
  • Table 2.1 Burn Assessment: The 'Rule of Nine' (%) Total Body Classification System
  • Table 2.2 The Classification of Burns by Depth: Degree Classification System
  • Table 2.3 The Classification of Burns by Severity
  • Table 2.4 Advanced Wound Care: Segments and Descriptions, 2016
  • Table 2.5 Advantages and Disadvantages of Moist Wound Care
  • Table 2.6 Advantages and Disadvantages of Skin Replacement Therapy
  • Table 2.7 Skin Graft Types and their Descriptions
  • Table 3.1 Global Wound Care Market by Sector: Revenue ($bn) and Market Share (%), 2017
  • Table 3.2 World Advanced Wound Care Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2016-2027
  • Table 4.1 Active Wound Care Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2016-2027
  • Table 4.2 Antimicrobial Dressings Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2016-2027
  • Table 4.3 Foam Dressings Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2016-2027
  • Table 4.4 Hydrocolloid Dressings Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2016-2027
  • Table 4.5 Film Dressings Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2016-2027
  • Table 4.6 Alginate Dressings Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2016-2027
  • Table 4.7 Hydrogel Dressings Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2016-2027
  • Table 4.8 SWOT Analysis of the Active Wound Care Dressings Market, 2017-2027
  • Table 5.1 Wound Care Device Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2015-2026
  • Table 5.2 NPWT Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2017-2027
  • Table 5.3 Ultrasound Wound Therapy Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2016-2027
  • Table 5.4 Other Wound Care Device Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2016-2027
  • Table 5.5 SWOT Analysis of the Wound Care Device Market, 2017-2027
  • Table 6.1 Wound Care Biologics Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2016-2027
  • Table 6.2 Skin Replacement Therapy Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2016-2027
  • Table 6.3 Collagen-Based Therapy Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2016-2027
  • Table 6.4 Cell-Based Therapy Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2016-2027
  • Table 6.5 Other Biologics Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2015-2026
  • Table 6.6 SWOT Analysis of the Wound Care Biologic Market, 2017-2027
  • Table 7.1 World Advanced Wound Care Market by Region: Revenues ($bn) and Market Share (%), 2016 and 2027
  • Table 7.2 World Advanced Wound Care Market Forecast by Region: Revenues ($bn), AGR (%), and CAGR (%), 2016-2027
  • Table 7.3 US Advanced Wound Care Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2016-2027
  • Table 7.4 EU5 Advanced Wound Care Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2016-2027
  • Table 7.5 German Advanced Wound Care Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2016-2027
  • Table 7.6 French Advanced Wound Care Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2016-2027
  • Table 7.7 UK Advanced Wound Care Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2016-2027
  • Table 7.8 Spanish Advanced Wound Care Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2016-2027
  • Table 7.9 Italian Advanced Wound Care Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2016-2027
  • Table 7.10 Japanese Advanced Wound Care Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2016-2027
  • Table 7.11 Chinese Advanced Wound Care Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2016-2027
  • Table 7.12 Indian Advanced Wound Care Market Forecast: Revenues (bn), AGR (%), CAGR (%), 2017-2027
  • Table 7.13 Russian Advanced Wound Care Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2016-2027
  • Table 7.14 Brazilian Advanced Wound Care Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2015-2026
  • Table 7.15 South Korean Advanced Wound Care Market Forecast: Revenues ($bn), AGR (%), CAGR (%), 2017-2027
  • Table 9.1 Smith & Nephew: Overview, 2017
  • Table 9.2 Smith & Nephew: Advanced Wound Care Revenue ($bn), AGR (%), CAGR (%), 2016-2027
  • Table 9.3 Acelity: Overview, 2016
  • Table 9.4 Acelity: Advanced Wound Care Revenue ($bn), AGR (%), CAGR (%), 2015-2026
  • Table 9.5 Mölnlycke: Overview, 2017
  • Table 9.6 ConvaTec: Overview, 2017
  • Table 9.7 ConvaTec: Advanced Wound Care Revenue ($bn) and AGR (%), 2016-2027
  • Table 9.8 Coloplast: Overview 2016
  • Table 9.9 Coloplast: Advanced Wound Care Revenue ($bn), AGR (%), CAGR (%), 2017-2027
  • Table 9.10 Organogenesis: Overview, 2016

Companies Listed

  • 3M
  • Acelity
  • Advanced BioHealing
  • Alliqua BioMedical
  • Anika Therapeutics
  • Arobella
  • Aspen
  • Avista Capital Partners
  • Avita Medical
  • B. Braun Medical
  • Bace Comércio Internacional
  • Beckton Dickinson
  • BexPharm
  • Boehringer
  • Brennan Medical
  • Bristol-Myers Squibb
  • C.R. Bard
  • Care Fusion
  • Celleration
  • Changchun JA Biotech
  • Coloplast
  • Convatec
  • Covalon
  • Covidien
  • Daewoong Pharmaceutical
  • Derma Sciences
  • Devon Medical Products
  • Dr. Suwelack Skin & Health Care
  • EdixoMed
  • ER Squibb & Sons
  • Forticell Bioscience
  • Fraunhofer Institute
  • Genadyne
  • Genewel
  • Genzyme
  • Hartmann
  • Healthpoint
  • Histocell
  • Human BioScience
  • Innocoll
  • Innovative Therapies
  • Integra Life Science
  • Kaken Parmaceuticals
  • KCI
  • Kimberley-Clark
  • Lescarden
  • LifeCell
  • Lightwave Technologies
  • Luqa Pharmaceuticals
  • MacroCure
  • Medela
  • MediWound
  • Medline
  • MiMedX
  • Misonix
  • Mölnlycke
  • Mo-Sci Corporation
  • Mundipharma
  • Nanotherapeutics
  • Nordic Capital Partners
  • Nuo Therapeutics
  • Organogenesis
  • Osiris Therapeutics
  • Politec Saúde
  • Prizm Medical
  • Promethean
  • Prospera
  • Sanuwave Health
  • Shandong Wego Newlife Medical Devices
  • Shire
  • Smith & Nephew
  • Soring
  • Spiracur
  • Synapse Microcurrent
  • Systagenix
  • Talley Group
  • TEI Biosciences
  • Urgo
  • Vario
  • Vomaris Innovations
  • Winner Medical Group
  • Wound Management Technologies
  • Zhejiang Top Medicals

Organizations Mentioned in the Report

  • Center for Medicare & Medicaid Services
  • Central Drug Standard Control Organisation
  • Centre for Devices and Radiological Health
  • Cornell University
  • Global Harmonisation Task Force
  • Harvard University - Institute of Photomedicine
  • International Diabetes Federation
  • McGowan Institute for Regenerative Medicine: University of Pittsburgh
  • Ministry of Health, Labour, and Welfare
  • Nara University
  • National Competent Authorities
  • National Health Service
  • Pharmaceuticals and Medical Devices Agency
  • RIKEN Center for Developmental Biology
  • Roszdravnadzor
  • Sistema Único de Saúde
  • United States Food and Drug Administration
  • University of California - Berkeley
  • World Health Organisation
Back to Top